NorthAvenue LLC’s Amgen AMGN Stock Holding History

NorthAvenue LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$725	Hold	2	–	–	﹤0.01%	246
2026 Q1	$704	Hold	2	–	–	﹤0.01%	209
2025 Q4	$655	Buy	+2	New	+$634	﹤0.01%	240

Other funds holding AMGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

NorthAvenue LLC's AMGN Position: Q2 2026 in Review

NorthAvenue LLC held its Amgen (AMGN) position steady in Q2 2026 at 2 shares worth $725. The position accounts for ﹤0.01% of the portfolio, ranked #246.

NorthAvenue LLC first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 758 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

NorthAvenue LLC held 2 shares of Amgen worth $725 as of Q2 2026.
NorthAvenue LLC left its Amgen share count unchanged in Q2 2026.
Amgen made up ﹤0.01% of NorthAvenue LLC's portfolio in Q2 2026, its #246 holding.
NorthAvenue LLC first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
758 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on NorthAvenue LLC's 13F filing for Q2 2026, filed 21 Jul 2026.